Pricing: What to Consider in Specialty Care and Biotech Markets?
By Avantika Daing
The author's views expressed in this publication do not necessarily reflect the views of the United States Agency for International Development or the United States Government.
Published: 2005
Avantika Daing is a Director of Marketing and Franchise Development at Eyetech Pharmaceuticals. Her expertise in pricing pharmaceutical agents and biologics was witnessed by many at the Willingness to Pay Panel. She presented on real-world experiences and constraints in pharmaceutical pricing.
Document Details
| Type of Document | Presentation |
|---|---|
| Countries | India |
| Topic(s) | Financing Mechanisms |
| Format | Adobe Acrobat (PDF) |
| File Size | 75 KB |
| Date posted | 05/2005 |
